Eir Diagnostics ApS: Financial statements 2025
CVR: 40339396
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Eir Diagnostics ApS (CVR 40339396) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 370,098 and a net result of DKK -16,645,537 compared with DKK -455,658 the year before. Equity in the 2025 report amounted to DKK -4,205,596.
- Gross Profit
- DKK 370,098
- Profit/Loss
- DKK -16,645,537
- Equity
- DKK -4,205,596
- Total Assets
- DKK 135,530
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 370 t. | -16.6 mio. | -4.2 mio. | 0 |
| 2024 | - | -13 t. | -456 t. | 12.4 mio. | 1 |
| 2023 | - | 1.1 mio. | -507 t. | 7.6 mio. | 3 |
| 2022 | - | 1.7 mio. | -594 t. | 7.6 mio. | 4 |
| 2021 | - | 1.2 mio. | -469 t. | 7.4 mio. | - |
How creditworthy is Eir Diagnostics ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Eir Diagnostics ApS has published its annual report for 2024. Gross profit came to DKK -13,347, and the net result was DKK -455,658.
About Eir Diagnostics ApS
Eir Diagnostics ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named AptaZense ApS. The management consists of Tine Walldén Jespersen. The company's owners include Danmarks Tekniske Universitet, KEMPHANSEN HOLDING ApS and PLASTISENS ApS. In 2025, the company reported a gross profit of DKK 370,098 and a net result of DKK -16,645,537 compared with DKK -455,658 the year before. Equity in the 2025 report amounted to DKK -4,205,596.